GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins (original) (raw)
Ferrara, C. et al. Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and co-expression of heterologous β1, 4-N-acetylglucosaminyltransferase III and Golgi α-mannosidase II. Biotechnol. Bioeng.93, 851–861 (2006). ArticleCAS Google Scholar
Elliott, S. et al. Control of rHuEPO biological activity: the role of carbohydrate. Exp. Hematol.32, 1146–1155 (2004). ArticleCAS Google Scholar
Jacobs, P.P., Geysens, S., Vervecken, W., Contreras, R. & Callewaert, N. Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology. Nat. Protoc.4, 58–70 (2008). Article Google Scholar
Hamilton, S.R. et al. Humanization of yeast to produce complex terminally sialylated glycoproteins. Science313, 1441–1443 (2006). ArticleCAS Google Scholar
Herter, S. et al. Preclinical activity of the type II CD20 antibody GA101 (obinutuzumab) compared with rituximab and ofatumumab in vitro and in xenograft models. Mol. Cancer Ther.12, 2031–2042 (2013). ArticleCAS Google Scholar
Kanda, Y. et al. Comparison of cell lines for stable production of fucose-negative antibodies with enhanced ADCC. Biotechnol. Bioeng.94, 680–688 (2006). ArticleCAS Google Scholar
Reeves, P.J., Callewaert, N., Contreras, R. & Khorana, H.G. Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line. Proc. Natl. Acad. Sci. USA99, 13419–13424 (2002). ArticleCAS Google Scholar
Stals, I. et al. Identification of a gene coding for a deglycosylating enzyme in Hypocrea jecorina. FEMS Microbiol. Lett.303, 9–17 (2010). ArticleCAS Google Scholar
Grundmann, U., Nerlich, C., Rein, T. & Zettlmeissl, G. Complete cDNA sequence encoding human β-galactoside α-2,6-sialyltransferase. Nucleic Acids Res.18, 667 (1990). ArticleCAS Google Scholar
Verstraete, K. et al. Structural insights into the extracellular assembly of the hematopoietic Flt3 signaling complex. Blood118, 60–68 (2011). ArticleCAS Google Scholar
Bernales, S., Papa, F.R. & Walter, P. Intracellular signaling by the unfolded protein response. Annu. Rev. Cell Dev. Biol.22, 487–508 (2006). ArticleCAS Google Scholar
Lee, F. et al. Isolation of cDNA for a human granulocyte-macrophage colony-stimulating factor by functional expression in mammalian cells. Proc. Natl. Acad. Sci. USA82, 4360–4364 (1985). ArticleCAS Google Scholar
Forno, G. et al. N- and O-linked carbohydrates and glycosylation site occupancy in recombinant human granulocyte-macrophage colony-stimulating factor secreted by a Chinese hamster ovary cell line. Eur. J. Biochem.271, 907–919 (2004). ArticleCAS Google Scholar
Crispin, M. et al. Inhibition of hybrid- and complex-type glycosylation reveals the presence of the GlcNAc transferase I-independent fucosylation pathway. Glycobiology16, 748–756 (2006). ArticleCAS Google Scholar
Ericsson, U.B., Hallberg, B.M., DeTitta, G.T., Dekker, N. & Nordlund, P. Thermofluor-based high-throughput stability optimization of proteins for structural studies. Anal. Biochem.357, 289–298 (2006). ArticleCAS Google Scholar
Kitamura, T. et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell. Physiol.140, 323–334 (1989). ArticleCAS Google Scholar
Mössner, E. et al. Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxicity. Blood115, 4393–4402 (2010). Article Google Scholar
Nallet, S. et al. Glycan variability on a recombinant IgG antibody transiently produced in HEK-293E cells. N. Biotechnol.29, 471–476 (2012). ArticleCAS Google Scholar
Jefferis, R. Glycosylation as a strategy to improve antibody-based therapeutics. Nat. Rev. Drug Discov.8, 226–234 (2009). ArticleCAS Google Scholar
Roopenian, D.C. & Akilesh, S. FcRn: the neonatal Fc receptor comes of age. Nat. Rev. Immunol.7, 715–725 (2007). ArticleCAS Google Scholar
Lux, A., Yu, X., Scanlan, C.N. & Nimmerjahn, F. Impact of immune complex size and glycosylation on IgG binding to human FcγRs. J. Immunol.190, 4315–4323 (2013). ArticleCAS Google Scholar
Hamblin, M.W. & Metcalf, M.A. Primary structure and functional characterization of a human 5–HT1D-type serotonin receptor. Mol. Pharmacol.40, 143–148 (1991). CASPubMed Google Scholar
Tradtrantip, L., Ratelade, J., Zhang, H. & Verkman, A.S. Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti–aquaporin-4 immunoglobulin G into therapeutic antibody. Ann. Neurol.73, 77–85 (2013). ArticleCAS Google Scholar
Nandakumar, K.S. et al. Dominant suppression of inflammation by glycan-hydrolyzed IgG. Proc. Natl. Acad. Sci. USA110, 10252–10257 (2013). ArticleCAS Google Scholar
Allhorn, M. & Collin, M. Sugar-free antibodies—the bacterial solution to autoimmunity? Ann. NY Acad. Sci.1173, 664–669 (2009). ArticleCAS Google Scholar
Anonymous. Biosimilar, biobetter and next generation therapeutic antibodies. MAbs3, 107–110 (2011).
MacLean, B. et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics26, 966–968 (2010). ArticleCAS Google Scholar
Tada, H., Shiho, O., Kuroshima, K., Koyama, M. & Tsukamoto, K. An improved colorimetric assay for interleukin 2. J. Immunol. Methods93, 157–165 (1986). ArticleCAS Google Scholar
Ramsland, P.A. et al. Structural basis for Fc γRIIa recognition of human IgG and formation of inflammatory signaling complexes. J. Immunol.187, 3208–3217 (2011). ArticleCAS Google Scholar
Magistrelli, G. et al. Robust recombinant FcRn production in mammalian cells enabling oriented immobilization for IgG binding studies. J. Immunol. Methods375, 20–29 (2012). ArticleCAS Google Scholar